Increased risk of central nervous system toxicity in patients treated with ciclosporin and imipenem/cilastatin

Nephron. 1991;58(3):362-4. doi: 10.1159/000186453.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Central Nervous System / drug effects
  • Central Nervous System Diseases / chemically induced
  • Central Nervous System Diseases / epidemiology*
  • Cilastatin / toxicity*
  • Cyclosporins / toxicity*
  • Female
  • Humans
  • Imipenem / toxicity*
  • Male
  • Middle Aged
  • Risk Factors

Substances

  • Cyclosporins
  • Cilastatin
  • Imipenem